Patents by Inventor Attila Lörincz

Attila Lörincz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6228578
    Abstract: A non-radioactive hybridization assay and kit for the detection of genetic defects, microbial infections or viral infections, such as human papillomavirus. A test sample is treated with a base and incubated with nucleic acid probes, diluted in a neutralizing buffer, specific for target nucleic acids. The hybrids are captured onto a solid phase coated with an anti-hybrid antibody, unhybridized probe is eliminated, and the bound hybrid detected.
    Type: Grant
    Filed: January 18, 1994
    Date of Patent: May 8, 2001
    Assignee: Digene Corporation
    Inventors: Chaka Impraim, Sharon Challberg, Attila Lörincz, Allison Cullen
  • Patent number: 6225053
    Abstract: An improved assay disclosed for detecting viral nucleic acid sequences. The improvement involves concentration viral particles from a biological sample by centrifugation. Once concentrated, the nucleic acid molecules in the viral particles can be manipulated or detected using any suitable procedure. Many such procedure are know and can be used with the concentrated viral nucleic acid molecules. Preferably, the concentrated viral nucleic acid is detected using a detection assay.
    Type: Grant
    Filed: December 12, 1997
    Date of Patent: May 1, 2001
    Assignee: Digene Corporation
    Inventors: Mariana Garcia, Ming Chan, Attila Lörincz